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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death in women in the United States. The
purpose of this study was to characterize the prevalence and awareness of traditional CVD risk factors, obe-
sity, and coronary heart disease (CHD) risk classification using the Framingham Risk Score (FRS) among women
attending the 2006 Sister to Sister National Woman’s Heart Day event.
Results: A total of 8936 participants (mean age 49  14 years) were evaluated. There was a modest prevalence
of traditional risk factors on screening, including non-high-density lipoprotein-cholesterol (HDL-C) 160
mg/dL (27%), HDL-C 40 mg/dL (16%), random glucose level 140 mg/dL (6%), uncontrolled blood pres-
sure 140/90 mm Hg (12%), current smoking (6%), and a positive family history of CHD (21%). There was a
high prevalence of overweight (39%) or obese individuals (35%) (body mass index [BMI] 25–30 and 30 kg/m2,
respectively), as well as those with high waist circumference (35 inches) (55%). Women were classified by
FRS as low (85%), intermediate (6%), and high risk (9%). When cardiometabolic risk analyses included waist
circumference in addition to the FRS, 59% of low-risk and 50% of intermediate-risk women had 1 or 2 risk fac-
tors, and 19% and 41% had 3 risk factors, respectively. Women were often unaware of risk factors on screen-
ing; among women without a previous diagnosis of dyslipidemia or hypertension, 48% and 7%, respectively,
were given new diagnoses.
Conclusions: Women participating in the 2006 Sister to Sister National Woman’s Heart Day event have a high
prevalence of cardiometabolic risk factors, especially dyslipidemia, obesity, and high central adiposity, that place
them at higher risk for the development of CVD and other comorbidities. The newly identified multiple risk fac-
tors in this population support the value of community health screening in women.
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Introduction
CARDIOVASCULAR DISEASE (CVD) has been the leading causeof death among women for nearly a century, with
women having higher CVD mortality rates than men yearly
since 1984.1 Women account for more than half of the nearly
1 million CVD deaths per year in the United States.2 Car-
diometabolic risk factors that contribute to the development
of clinically significant CVD and other comorbidities are of-
ten unrecognized by women and their physicians, and risk
factors are often undertreated when they are recognized.3–5
As 25% of sudden cardiac death occurs among individu-
1Sister to Sister, Everyone Has a Heart Foundation, Bethesda, Maryland.
2The Johns Hopkins Ciccarone Preventive Cardiology Center, Baltimore, Maryland.
3Shattuck & Associates, Inc., Mt. Airy, Maryland.
4Massachusetts General Hospital Cardiac MRI PET CT Program, Boston, Massachusetts.
5Division of Cardiology, University of California San Francisco, San Francisco, California.
6Catholic University of America, National Catholic School of Social Service, Washington, DC.
This work was supported by the nonprofit Sister to Sister, Everyone Has a Heart Foundation, Bethesda, MD. E.D.M. is partially funded
by the P.J. Schafer Memorial Cardiovascular Research Fund.
als with no prior symptoms of CVD, it is imperative to iden-
tify risk factors for CVD and implement preventive strate-
gies, such as lifestyle changes.2
Although progress has been made in raising awareness
about heart disease, nearly half of all women fail to real-
ize the association between risk factors, such as high blood
pressure, and their own risk of developing CVD.6 In a re-
cent study examining physicians’ awareness of CVD in
women, researchers found that 1 in 5 physicians were
aware that more women than men die each year from CVD;
it is noteworthy that cardiologists represented one third of
the sample.7
The purpose of this study is threefold: first, to character-
ize the cardiometabolic risk profiles, including waist cir-
cumference (WC), of women attending the 2006 Sister to Sis-
ter National Woman’s Heart Day event; second, to examine
the participants’ predicted 10-year risk of hard coronary
heart disease (CHD) events by the Framingham Risk Score
(FRS); and third, to establish the proportion of women at-
tending the Heart Day event who had newly identified risks
for CVD. Sister to Sister is a national grassroots, nonprofit
foundation that educates women about heart disease and
provides free cardiovascular risk screenings in an effort to
encourage women to make necessary lifestyle changes to
prevent or reduce their risk of heart disease.
Materials and Methods
Design and subjects
On February 17, 2006, the Sister to Sister, Everyone Has a
Heart Foundation held its annual free public screening event
in 14 cities across the United States. A total of 9404 women
underwent screening at this event, which had been publi-
cized during the prior month in local newspapers, by pub-
lic service advertisements on television and radio, and by
other grassroots outreach efforts. The screening included a
standardized questionnaire, a physical screening for stan-
dardized cardiometabolic risk factors, receipt of health edu-
cation materials, and counseling. Health education materi-
als included national standardized education materials
about lifestyle approaches to risk reduction based on the
American Heart Association (AHA) Evidence-Based Guide-
lines for Cardiovascular Disease Prevention.8 Participants
also could view demonstrations by nutrition and fitness pro-
fessionals and learn about lifestyle changes to improve heart
health. Each individual was counseled by trained healthcare
staff on their risk profile. Bilingual staff was available in 12
of the 14 cities.
All participants of the screening event were included in
the study with the exception of men (n  442), respondents
with missing age data (n  262), and women who were out-
side established age ranges: 18 years (n  27) and 80
years (n  179).
Standardized questionnaire
The standardized questionnaire was designed to gather
demographic data, medical history, medication use, and
family history of CHD. Family history of premature CHD
was defined as having a first-degree relative (parent, child,
or sibling) with a heart attack, coronary bypass, or angio-
plasty before the age of 55 in male relatives or before the age
of 65 in female relatives. A personal history of CVD was de-
fined as a self-reported history of CHD, heart attack, stroke,
peripheral arterial disease, carotid artery stenosis, angio-
plasty, coronary stent, or bypass surgery. Unfortunately,
data about hormone therapy was not collected.
Cardiometabolic risk factor screening
The physical screenings included measurement of the fol-
lowing cardiometabolic risk factors: blood pressure, body
mass index (BMI), WC, random nonfasting glucose, and non-
fasting total cholesterol and high-density lipoprotein cho-
lesterol (HDL-C). Standardized protocols for screening as-
sessment of the cardiometabolic risk factors listed were
consistent with the previously developed methods published
from the 2005 Sister to Sister, Everyone Has a Heart screen-
ing program.9 Newly defined hypertension was defined as
a systolic blood pressure 140 mm Hg or diastolic blood
pressure 90 mm Hg or both. Non-HDL-C was defined as
total cholesterol minus HDL-C. Dyslipidemia was defined
by having a non-HDL-C 160 mg/dL or an HDL-C 50
mg/dL; the latter was chosen because this is the level of
HDL-C that is considered low for women in the National
Cholesterol Education Program (NCEP) definition of meta-
bolic syndrome.10
Non-Asian women with a WC 35 inches or Asian women
with a WC 31 inches were defined as having increased cen-
tral adiposity.11 Women with a BMI between 25 and 29.9
kg/m2 were defined as overweight, and those with a BMI
30 kg/m2 were defined as obese. Increased central adi-
posity by WC was used in assessment of cardiometabolic
risk11 except in 915 women (10.7% of sample population) in
whom WC was not obtained; in these cases, a conservative
measurement of BMI 30 was used instead.
Framingham risk score
An FRS was calculated for each participant using the NCEP
Adult Treatment Panel (ATP) III algorithm to determine pre-
dicted 10-year risk for hard CHD events (fatal and nonfatal
myocardial infarction [MI]). Individuals were classified as
high, intermediate, or low risk by FRS defined by a 10-year
CHD risk of 20%, 10%–20%, or 10%, respectively.10
Data management and statistics
All data were collected on standardized screening forms
and entered into a Microsoft ACCESS database by city. Data
were then transferred into an SPSS file (SPSS, Inc., Chicago,
IL) and merged into one aggregate file. Analysis was con-
ducted using SPSS version 11.0.1. Nominal data are pre-
sented as number and percent of total. Continuous data are
presented as mean with standard deviation (SD). Frequency
and cross-tabulations were conducted to examine relation-
ships among numbers of risk factors, individual risk factors,
and Framingham Risk estimate.
Results
The study population consisted of 8936 women aged 18–80
years (mean 49  14 years) of diverse demographic and clin-
ical characteristics (Table 1). Nearly two thirds of partici-
pants were members of a racial/ethnic minority group. The
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age and racial distributions of the 2006 participants were sim-
ilar to those of women attending the 2005 screening day.9
Only 4% of the study participants (n  359, mean age 57 
13 years) reported a previous diagnosis of CVD. Of those,
73% reported a history of heart attack or coronary artery
revascularization procedure, and 37% reported a history of
carotid artery disease or stroke. Medication and supplement
use was reported by 40% of all respondents. Of these indi-
viduals, 25% reported taking an herbal, nutritional, or vita-
min supplement to prevent heart disease. One fifth of all par-
ticipants reported a family history of premature CHD (21%),
and over a quarter (28%) reported a history of high blood
pressure.
Screening results (Table 2) demonstrated that 27% of
women had high non-HDL-C, 40% had low HDL-C, and 33%
had a history of high blood pressure or newly diagnosed
high blood pressure (Tables 1 and 2). Over half (58%) of
women fell into the prehypertension category (blood pres-
sure 120/80 but  140/90 mm Hg). Based on BMI mea-
sures, three quarters of all women were deemed to be over-
weight (39%) or obese (35%). WC was elevated in 55% of
participants.
Participants without a previous a history of CVD were
stratified by FRS (Table 3). Results demonstrate that 85%
were considered low risk by FRS (10 % 10-year hard CHD
risk). When cardiometabolic factors, including increased WC
(or obesity in cases of missing data), were added to the tra-
ditional risk factors defining the FRS (Table 4), of those
women classified by FRS as low risk, 19% had 3 risk fac-
tors, and among those classified as intermediate risk, 41%
had 3 risk factors. In women with low FRS, obesity was
the most prevalent cardiometabolic risk factor (Table 5).
When comparing risk factor levels between women with
and without a WC measurement, several differences
emerged. Women without a WC measure were significantly
more likely than those with a measure to be older (p 
0.0001), to have higher diastolic blood pressure (p  0.008),
and to have a lower BMI (p  0.0001). There were no differ-
ences in measures of systolic blood pressure, total choles-
terol, or HDL-C.
Many women learned of previously undiagnosed risk fac-
tors by screening (Fig. 1). Among women without a previ-
ous diagnosis of hypercholesterolemia, 36% had a non-HDL-
C 160 mg/dL, 38% had an HDL-C 50 mg/dL, and 48%
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TABLE 1. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF FEMALE PARTICIPANTS
Number














Completed 2–4 years of college or certification program 5006 56
Clinical characteristics
Cardiovascular disease 359 4
Heart attack/blocked arteries in heart or brain 216 2
Angioplasty or stent 86 1
Coronary bypass surgery 43 1
Stroke or carotid artery disease 134 2
Diabetes 518 6
History of high blood pressure 2519 28
History of high cholesterol 2263 25
Faily history of CHD 1887 21
Taking medication
Cholesterol 1076 12
Blood pressure 1967 2
Diabetes 453 5
Blood thinner 182 2
Aspirin 1560 18
Herbal therapies, nutritional supplements, or 892 10
vitamin supplements to prevent heart disease
Smoker
Current smoker 532 6
Past smoker 1147 13
had an abnormal non-HDL-C or HDL-C. Among women
with no prior history of hypertension, 7% were found to have
a blood pressure  140/90 mm Hg.
Discussion
Cardiometabolic risk factors and FRS
This study demonstrates that multiple cardiometabolic
risk factors are extremely prevalent in women participating
in a community health screening even among a population
of presumed generally healthy women, where 85% of par-
ticipants fell into the low 10-year CHD risk category by the
FRS. Among these low-risk women, notably, the most preva-
lent risk factor was being overweight, with 50% having an
increased WC. The high prevalence of obesity was followed
by the relatively high prevalence of low HDL-C (38%), high
non-HDL-C (21%), and family history of premature CHD
(20%). When increased central adiposity or obesity was in-
cluded in risk assessment among women classified low-risk
by the FRS, 59% had 1 or 2 risk factors, and an additional
20% had 3 risk factors. About a third of the low-risk women
with an elevated random glucose or hypertension or who
were smokers had 3 other risk factors (34%, 26%, and 28%
respectively). It is important to note, though, that the FRS
predicts 10-year CHD risk and not total CVD risk. These find-
ings highlight that many of these low-risk women by the FRS
have high lifetime risk of metabolic syndrome and CVD.
Other smaller studies have reported similar findings.12,13
Recent data from the Framingham Heart Study of women
free of CVD at 50 years of age found that lifetime risk for
CVD events was 40% for women, which exceeds the lifetime
risk of breast cancer, lung cancer, and colorectal cancer com-
bined.14 Unfortunately, few women in the Framingham
Study had optimal levels of risk factors at age 50 (5%). Only
8% of women without risk factors at age 50 developed CVD
events compared with 50% of women with 2 risk factors;
thus, low-risk CVD status at 50 years of age conferred upon
low-risk women an excess of 8 years of survival.14 The pres-
ence of any risk factor at age 50 increases the lifetime CVD
risk in women, with the presence of diabetes conferring the
greatest risk (57% risk of developing CVD through 75 years
of age). This reinforces the importance of preventive efforts,
such as lifestyle modifications, to begin early in life; even the
presence of a single major risk factor by middle age is asso-
ciated with shorter survival.
The low-risk classification of these women with high life-
time risk of CVD has important clinical implications, as the
NCEP Guidelines for use of aspirin and lipid-lowering med-
ication in primary prevention are based on the FRS for hard
CHD events.10 Because more points are assigned to chrono-
logical age in the FRS risk prediction, younger individuals typ-
ically have very low 10-year risks but may still have substan-
tial lifetime risks. Low risk is not the same as no risk, but the
label of low risk status by the FRS can potentially lead to false
reassurance and may lower motivation to engage in lifestyle
modifications. Furthermore, in a recent study, physicians were
significantly more likely to assign intermediate-risk women
than intermediate-risk men to the low-risk category.7 Assign-
ment of risk level significantly predicted the types of lifestyle
changes and preventive pharmacotherapy that physicians
would recommend,7 as patients with a low FRS were signifi-
cantly less likely than patients with an intermediate or high
FRS to receive counseling about physical activity and diet.
Even when their FRS is comparable, women receive fewer pre-
vention recommendations, such a lipid-lowering therapy, as-
pirin, and lifestyle advice, than do men.7,15
The recent AHA 2007 Updates to the Cardiovascular Pre-
ventive Guidelines for Women8 acknowledged some of the
limitations of FRS and, therefore, recommended a new scheme
for CVD risk classification in women of high risk, at-risk, and
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Blood pressure (mm Hg)
120/80 2738 31
120–139/80–89 (prehypertensive) 5155 58
140/90 (hypertensive) 1033 12
BMI (kg/m2)
25 2354 27
25–29.9 (overweight) 3459 39




TABLE 3. FRAMINGHAM RISK LEVELa





aExcludes participants with CVD (n  359).
TABLE 4. COMPARISON OF FRAMINGHAM RISK SCORES AND
NUMBER OF CARDIOMETABOLIC RISK FACTORSa
Number of
CVD risk Low Intermediate High
factors n % n % n %
0 1600 22 47 10 70 9
1–2 4231 59 242 50 359 45
3 1369 19 197 41 378 47
aCardiometabolic risk factors include hypertension (140/90
mm Hg); non-HDL-cholesterol (160 mg/dL); HDL-cholesterol
(50 mg/dL); non-fasting glucose (140 mg/dL); smoker; family
history; WC 35 inches (31 inches for Asian women) or, if no WC
measure, BMI 30 kg/m2.
Framingham risk score
optimal risk. Whereas women with established CVD and di-
abetes still fell into the high-risk category, women who have
even one major CVD risk factor were acknowledged to be at
increased lifetime risk for CVD. Other women at increased
lifetime risk of CVD include those with evidence of subclini-
cal CVD with or without risk factors, poor exercise capacity,
or unhealthy lifestyles including poor diet, reduced physical
activity, and obesity.8 Optimal risk in the AHA prevention
guidelines was considered to be an FRS  10% and a healthy
lifestyle with no CVD risk factors. The addition of an optimal
risk category can be used to reassure some women while mo-
tivating others.
Obesity and risk
Obesity is a significant CVD risk factor in nearly all the
world’s populations.16 Additionally, obese persons are more
likely to develop the comorbid conditions of type 2 diabetes
mellitus, dyslipidemia, hypertension, osteoarthritis, gall-
bladder disease, liver disease, and certain cancers.17 Along
with traditional risk factors of elevated blood pressure, blood
glucose, and lipid levels, WC can further aid in identifying
patients at risk for CVD in a primary care setting.18 Identi-
fication of obesity and central adiposity at an earlier age pre-
sents an opportunity for risk reduction through targeted in-
terventions well before CVD or other comorbidities become
clinically manifest.
Studies have demonstrated that active women have lower
CVD risk than inactive women, and even light to moderate
activity is associated with CVD risk reduction.19,20 A reduc-
tion in WC by caloric restriction and increased amount of
moderate intensity activity may directly reduce the car-
diometabolic risk profile of obese individuals.21 Accordingly,
the NIH Guidelines recommend a combination of a low-calo-
rie diet, increased physical activity, and behavioral therapy
as the first-line intervention for weight loss and weight main-
tenance in overweight persons with risk factors or in the
obese.22
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Risk factor factor n % n % n %
Non-HDL cholesterol (160 mg/dL) 21 311 14 1527 67 442 19
HDL-cholesterol (50 mg/dL) 38 618 19 2217 67 495 15
Hypertension (140/90 mm Hg) 11 91 9 634 65 248 26
Random glucose (140 mg/dL) 5 54 11 257 54 163 34
Smoking 4 66 13 299 59 141 28
WCb 50 1047 24 2822 64 531 12
Family history 20 351 20 1069 61 333 19
aNumber of other risk factors excludes the current risk factor.
bWC  35 inches (31 inches for Asian women) or if no WC measure, BMI 30 kg/m2.
Number of other risk factors
0 1–2 3 or more
FIG. 1. Percent of newly identified risk factors during health screening.
Value of screening events
The results of this study support the value of screening
events in raising awareness of the causes of heart disease.
Cardiometabolic risk factors were common in this cohort. In
addition, 48% of women with no previous diagnosis of dys-
lipidemia and 7% with no prior diagnosis of hypertension
were found to be at risk at the screening event compared
with 47% with newly diagnosed dyslipidemia and 16%
newly diagnosed hypertension in the 2005 Sister to Sister
screening day.9 These results support the literature showing
that a large number of women continue to be at high life-
time cardiovascular risk.14
Fortunately, women are becoming more aware of the dan-
gers of heart disease. In a 2006 AHA survey, 57% of women
correctly responded that heart disease is the number one
killer of women, up from 34% in 2000.23 This AHA survey
also demonstrated that a woman’s knowledge about her per-
sonal risk of heart disease was correlated with increased ac-
tion to modify risk. However, about one third of women sig-
nificantly underestimated their personal risk.
A woman’s knowledge about personal risk previously cor-
related with increased action to lower that risk.6 Follow-up
data in a random subpopulation of women attending the
2006 Sister to Sister National Woman’s Heart Day event (n 
157) reinforce these findings. Almost three quarters (72%) of
the follow-up sample reported following up on recommen-
dations made at the screening day to see a healthcare
provider. Most of these (71%) reported going to a doctor’s
office for this follow-up care. In addition, the results indicate
these women took additional steps to reduce CVD risk. For
example, since attending the Heart Day event, 64% reported
changing their diet, 47% losing weight, 23% measuring their
waistline, 61% monitoring their blood pressure, 61% in-
creasing their physical activity, 6% stopping smoking, and
20% starting stress management strategies.
Study limitations
Over 8900 women across 14 cities were represented in this
study, but these women were not necessarily representative
of the general population of American women. Self-selection
to participate may lead to a source of bias in the sample, al-
though a strength of this study is that data were collected
from a community sample and may be less influenced by
healthy volunteer bias. Additional research should be con-
ducted with other demographic groups, such as specific
racial/ethnic, age, and socioeconomic groups to validate the
results of the study.
Measurement error is another possible limitation of the
study. Although steps were taken to minimize error, such as
standardized screening protocols across measurement sites, the
possibility still exists that some risk factors were misclassified.
Approximately 1 in 10 women in this study opted out of the
WC measurement. This suggests that this measurement may
not be suitable for all settings and that the percentage of women
with increased WC in our sample may be underestimated.
There were significant limitations on how risk factors were
diagnosed. Although the NCEP advises a 9–12-hour fast be-
fore cholesterol screening is performed, the diagnoses of dys-
lipidemia and hyperglycemia in this study were made based
on a single nonfasting blood draw. In addition, hypertension
was diagnosed by an elevated blood pressure on a single
screening day, but per the AHA guidelines, hypertension
should be confirmed with at least two other measurements
on two or more separate visits after the initial screening. Fi-
nally, past medical history was self-reported by participants.
A woman might not have reported a prior history of dys-
lipidemia or hypertension, whereas medical records if avail-
able might have reflected otherwise, which may have influ-
enced our determination of the prevalence of newly
diagnosed risk factors. However, even if these risk factors
had been previously diagnosed in their medical records, the
women with newly diagnosed risk factors were unaware of
these risk factors and were not at optimal goals.
Conclusions
A high percentage of women attending the 2006 National
Woman’s Heart Day event were found to have modifiable
cardiometabolic risk factors. The majority of women were
found to have a low global risk by FRS despite having mul-
tiple cardiometabolic risk factors, suggesting that evaluation
of other risk factors should be used in conjunction with the
FRS to fully estimate a woman’s risk for CVD. Identification
of multiple risk factors in women participating in this study
demonstrates the value of screening events, such as the Sis-
ter to Sister, Everyone Has a Heart Foundation free public
screening events. Indeed, limited follow-up with a subset of
the participants indicated that many of them took actions af-
ter the Heart Day Event to reduce their CVD risk.
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